-
Grupo 25 Bronchodilator activity of the selective muscarinic antagonist revatropate in horses with heaves.pdf 19 Ago 201419/08/14 a las 09:37 hrs.2014-08-19 09:37:19
Daniela Iraguen C.
-
Grupo 24 Risk of septic arthritis after intra-articular medication.pdf 19 Ago 201419/08/14 a las 09:36 hrs.2014-08-19 09:36:19
Daniela Iraguen C.
-
Grupo 22 Pharmacokinetics of imipenem after intravenous, intramuscular and subcutaneous administration to cats..pdf 19 Ago 201419/08/14 a las 09:36 hrs.2014-08-19 09:36:19
Daniela Iraguen C.
-
Grupo 23 Investigation of the migration of triclabendazole residues.pdf 19 Ago 201419/08/14 a las 09:36 hrs.2014-08-19 09:36:19
Daniela Iraguen C.
-
Grupo 21 Efficacy and safety of 3 versus 5 days of meloxicam.pdf 19 Ago 201419/08/14 a las 09:35 hrs.2014-08-19 09:35:19
Daniela Iraguen C.
-
Grupo 20 The pharmacokinetics of maropitant citrate dosed orally.pdf 19 Ago 201419/08/14 a las 09:35 hrs.2014-08-19 09:35:19
Daniela Iraguen C.
-
Grupo 19 Fipronil–amitraz–S-methoprene-triggered pemphigus.pdf 19 Ago 201419/08/14 a las 09:34 hrs.2014-08-19 09:34:19
Daniela Iraguen C.
-
Grupo 18 Enoxaparin Pharmacokinetics and treatment schedule for cats.pdf 19 Ago 201419/08/14 a las 09:34 hrs.2014-08-19 09:34:19
Daniela Iraguen C.
-
Grupo 17 The Pharmacokinetics of Mirtazapine in Cats with Chronic Kidney.pdf 19 Ago 201419/08/14 a las 09:33 hrs.2014-08-19 09:33:19
Daniela Iraguen C.
-
Grupo 16 CYP450-Dependent Biotransformation of the Insecticide Fipronil into.pdf 19 Ago 201419/08/14 a las 09:33 hrs.2014-08-19 09:33:19
Daniela Iraguen C.
-
Grupo 15 Is switching from brand name to generic formulations of phenobarbital associated with.pdf 19 Ago 201419/08/14 a las 09:33 hrs.2014-08-19 09:33:19
Daniela Iraguen C.
-
Grupo 14 Pharmacokinetics and bioequivalence in the pig of two ivermectin feed.pdf 19 Ago 201419/08/14 a las 09:32 hrs.2014-08-19 09:32:19
Daniela Iraguen C.
-
Grupo 13 Comparative efficacy of inhaled albuterol between two hand-held delivery devices in horses.pdf 19 Ago 201419/08/14 a las 09:32 hrs.2014-08-19 09:32:19
Daniela Iraguen C.
-
Grupo 12 Depletion study and estimation of the withdrawal period for enrofloxacin in pacu.pdf 19 Ago 201419/08/14 a las 09:32 hrs.2014-08-19 09:32:19
Daniela Iraguen C.
-
Grupo 11 Plasma concentrations and therapeutic effects of budesonide in dogs.pdf 19 Ago 201419/08/14 a las 09:32 hrs.2014-08-19 09:32:19
Daniela Iraguen C.
-
Grupo 10 Maropitant prevented vomiting but not gastroesophageal reflux.pdf 19 Ago 201419/08/14 a las 09:31 hrs.2014-08-19 09:31:19
Daniela Iraguen C.
-
Grupo 9 Evaluation of metoclopramide and ranitidine on the prevention of gastroesophageal.pdf 19 Ago 201419/08/14 a las 09:30 hrs.2014-08-19 09:30:19
Daniela Iraguen C.
-
Grupo 8 Efficacy of orally administered maropitant citrate.pdf 19 Ago 201419/08/14 a las 09:30 hrs.2014-08-19 09:30:19
Daniela Iraguen C.
-
Grupo 7 Comparison of tiletamine and zolazepam pharmacokinetics in tigers.pdf 19 Ago 201419/08/14 a las 09:30 hrs.2014-08-19 09:30:19
Daniela Iraguen C.
-
Grupo 6 The influence of modulation of P-glycoprotein and or Cytochrome P450.pdf 19 Ago 201419/08/14 a las 09:30 hrs.2014-08-19 09:30:19
Daniela Iraguen C.
-
Grupo 5 Effects of acute hepatic and renal failure on pharmacokinetics of flumixin meglumine in rats.pdf 19 Ago 201419/08/14 a las 09:29 hrs.2014-08-19 09:29:19
Daniela Iraguen C.
-
Grupo 4 Influence of P-glycoprotein modulation on plasma concentrations and pharmacokinetics.pdf 19 Ago 201419/08/14 a las 09:29 hrs.2014-08-19 09:29:19
Daniela Iraguen C.
-
Grupo 3 Pharmacokinetics of cefpirome following IV and IM admonistration in cow calves.pdf 19 Ago 201419/08/14 a las 09:29 hrs.2014-08-19 09:29:19
Daniela Iraguen C.
-
Grupo 2 Bioequivalence in dogs of a meloxicam formulation administered as a.pdf 19 Ago 201419/08/14 a las 09:29 hrs.2014-08-19 09:29:19
Daniela Iraguen C.
-
Grupo 1 Bioequivalence of Orally Administered Generic, Compounded, and.pdf 19 Ago 201419/08/14 a las 09:29 hrs.2014-08-19 09:29:19
Daniela Iraguen C.